Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial

Authors: Josep M. Grinyó, María del Carmen Rial, Josefina Alberú, Steven M. Steinberg, Roberto Ceratti Manfro, Georgy Nainan, Flavio Vincenti, Charlotte Jones-Burton, Nassim Kamar - American Journal of Kidney Diseases 2016 cited by 109